Modest von Korff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Modest von Korff has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Sander
Scientific Computing Drug Discovery, Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland
4 shared publications Thomas Sander
Idorsia Pharmaceuticals Ltd, CH-4123 Allschwil
2 shared publications- Isabelle Reymond
Idorsia Pharmaceuticals Ltd
1 shared publication - Joel Freyss
Global Information Systems, Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123, Allschwil, Switzerland
1 shared publication - Joel Wahl
Scientific Computing Drug Discovery, Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland
1 shared publication - John Gatfield
Idorsia Pharmaceuticals Ltd
1 shared publication
Latest Publications
- Open Access
- 26 April 2023
- Published by Swiss Chemical Society in Chimia
- Vol. 77 (4) , 258
Molecular Complexity for Chemical Reactions
A new method is presented on how to calculate molecular complexity for chemical reactions by the fractal dimension of educts and products. Two pathways for the total synthesis of strychnine were compared. Significant differences in the two synthesis pathways were reflected by reaction complexity. These results demonstrate that reaction complexity is a powerful measure to group chemical reactions beyond substructural changes.
- 26 April 2023
- Published by Swiss Chemical Society in Chimia
- Vol. 77 (4) , 258
Open AccessMolecular Complexity for Chemical Reactions
A new method is presented on how to calculate molecular complexity for chemical reactions by the fractal dimension of educts and products. Two pathways for the total synthesis of strychnine were compared. Significant differences in the two synthesis pathways were reflected by reaction complexity. These results demonstrate that reaction complexity is a powerful measure to group chemical reactions beyond substructural changes.
- Open Access
- 10 March 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 832120
Limits of Prediction for Machine Learning in Drug Discovery
In drug discovery, molecules are optimized towards desired properties. In this context, machine learning is used for extrapolation in drug discovery projects. The limits of extrapolation for regression models are known. However, a systematic analysis of the effectiveness of extrapolation in drug discovery has not yet been performed. In response, this study examined the capabilities of six machine learning algorithms to extrapolate from 243 datasets. The response values calculated from the molecules in the datasets were molecular weight, cLogP, and the number of sp3-atoms. Three experimental set ups were chosen for response values. Shuffled data were used for interpolation, whereas data for extrapolation were sorted from high to low values, and the reverse. Extrapolation with sorted data resulted in much larger prediction errors than extrapolation with shuffled data. Additionally, this study demonstrated that linear machine learning methods are preferable for extrapolation.
- 10 March 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 832120
Open AccessLimits of Prediction for Machine Learning in Drug Discovery
In drug discovery, molecules are optimized towards desired properties. In this context, machine learning is used for extrapolation in drug discovery projects. The limits of extrapolation for regression models are known. However, a systematic analysis of the effectiveness of extrapolation in drug discovery has not yet been performed. In response, this study examined the capabilities of six machine learning algorithms to extrapolate from 243 datasets. The response values calculated from the molecules in the datasets were molecular weight, cLogP, and the number of sp3-atoms. Three experimental set ups were chosen for response values. Shuffled data were used for interpolation, whereas data for extrapolation were sorted from high to low values, and the reverse. Extrapolation with sorted data resulted in much larger prediction errors than extrapolation with shuffled data. Additionally, this study demonstrated that linear machine learning methods are preferable for extrapolation.
- Open Access
- 9 September 2019
- Published by Springer Nature
- p. 741-746
Predictive Power of Time-Series Based Machine Learning Models for DMPK Measurements in Drug Discovery
Four datasets measuring DMPK (drug metabolism and pharmacokinetics) parameters, and one target protein-specific dataset were analyzed by machine learning methods. Parameters measured for the five compound sets were biological activity data, plasma protein binding, permeability in MDCK I cell layers, intrinsic clearance by human liver microsomes, and plasma exposure in orally dosed rats. The measured data were sorted chronologically, reflecting the order in which they had been obtained in the discovery project. Subsets of the chronologically sorted data that appeared early in the project were used as training datasets to build predictive models for subsequent compounds based on kNN, partial least squares regression (PLSR), nonlinear PLSR, random forest regression, and support vector regression. A median model was used as a baseline to assess the machine learning model prediction quality. Data sets sorted in order of increasing test set prediction error: intrinsic clearance, plasma protein binding, cell layer permeability, biological activity on target protein, and bioavailability as AUC in rats. Our results give a first estimation of the power of machine learning to predict DMPK properties of compounds in an ongoing drug discovery project.
- 9 September 2019
- Published by Springer Nature
- p. 741-746
Open AccessPredictive Power of Time-Series Based Machine Learning Models for DMPK Measurements in Drug Discovery
Four datasets measuring DMPK (drug metabolism and pharmacokinetics) parameters, and one target protein-specific dataset were analyzed by machine learning methods. Parameters measured for the five compound sets were biological activity data, plasma protein binding, permeability in MDCK I cell layers, intrinsic clearance by human liver microsomes, and plasma exposure in orally dosed rats. The measured data were sorted chronologically, reflecting the order in which they had been obtained in the discovery project. Subsets of the chronologically sorted data that appeared early in the project were used as training datasets to build predictive models for subsequent compounds based on kNN, partial least squares regression (PLSR), nonlinear PLSR, random forest regression, and support vector regression. A median model was used as a baseline to assess the machine learning model prediction quality. Data sets sorted in order of increasing test set prediction error: intrinsic clearance, plasma protein binding, cell layer permeability, biological activity on target protein, and bioavailability as AUC in rats. Our results give a first estimation of the power of machine learning to predict DMPK properties of compounds in an ongoing drug discovery project.
- Open Access
- 7 August 2019
- Published by Springer Nature in Journal of Cheminformatics
- Vol. 11 (1) , 1-10
Accuracy evaluation and addition of improved dihedral parameters for the MMFF94s
The Platinum dataset of protein-bound ligand conformations was used to benchmark the ability of the MMFF94s force field to generate bioactive conformations by minimization of randomly generated conformers. Torsion angle parameters that generally caused wrong geometries were reparameterized by conducting dihedral scans using ab initio calculations at the MP2 level. This reparameterization resulted in a systematic improvement of generated conformations.
- 7 August 2019
- Published by Springer Nature in Journal of Cheminformatics
- Vol. 11 (1) , 1-10
Open AccessAccuracy evaluation and addition of improved dihedral parameters for the MMFF94s
The Platinum dataset of protein-bound ligand conformations was used to benchmark the ability of the MMFF94s force field to generate bioactive conformations by minimization of randomly generated conformers. Torsion angle parameters that generally caused wrong geometries were reparameterized by conducting dihedral scans using ab initio calculations at the MP2 level. This reparameterization resulted in a systematic improvement of generated conformations.
- Open Access
- 30 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-8
Molecular Complexity Calculated by Fractal Dimension
Molecular complexity is an important characteristic of organic molecules for drug discovery. How to calculate molecular complexity has been discussed in the scientific literature for decades. It was known from early on that the numbers of substructures that can be cut out of a molecular graph are of importance for this task. However, it was never realized that the cut-out substructures show self-similarity to the parent structures. A successive removal of one bond and one atom returns a series of fragments with decreasing size. Such a series shows self-similarity similar to fractal objects. Here we used the number of distinct fragments to calculate the fractal dimension of the molecule. The fractal dimension of a molecule is a new matter constant that incorporates all features that are currently known to be important for describing molecular complexity. Furthermore, this is the first work that reveals the fractal nature of organic molecules.
- 30 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-8
Open AccessMolecular Complexity Calculated by Fractal Dimension
Molecular complexity is an important characteristic of organic molecules for drug discovery. How to calculate molecular complexity has been discussed in the scientific literature for decades. It was known from early on that the numbers of substructures that can be cut out of a molecular graph are of importance for this task. However, it was never realized that the cut-out substructures show self-similarity to the parent structures. A successive removal of one bond and one atom returns a series of fragments with decreasing size. Such a series shows self-similarity similar to fractal objects. Here we used the number of distinct fragments to calculate the fractal dimension of the molecule. The fractal dimension of a molecule is a new matter constant that incorporates all features that are currently known to be important for describing molecular complexity. Furthermore, this is the first work that reveals the fractal nature of organic molecules.
- 20 December 2012
- Published by Springer Nature
- p. 301-306
About Complexity and Self-Similarity of Chemical Structures in Drug Discovery
- 20 December 2012
- Published by Springer Nature
- p. 301-306
About Complexity and Self-Similarity of Chemical Structures in Drug Discovery